Detalles de la búsqueda
1.
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.
Cancers (Basel)
; 11(9)2019 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31514446
2.
Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell Carcinoma.
Transl Oncol
; 11(1): 168-174, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29289845
3.
Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States.
J Gastrointest Oncol
; 7(6): 996-1003, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28078124
4.
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.
Ecancermedicalscience
; 10: 676, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27729941
5.
Oncolytic virotherapy for head and neck cancer: current research and future developments.
Oncolytic Virother
; 4: 83-93, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-27512673
6.
Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.
J Immunother
; 37(7): 360-5, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25075565
Resultados
1 -
6
de 6
1
Próxima >
>>